| Time lines of infection and disease in human influenza: a review of volunteer challenge studies F Carrat, E Vergu, NM Ferguson, M Lemaitre, S Cauchemez, S Leach, ... American journal of epidemiology 167 (7), 775-785, 2008 | 1422 | 2008 |
| Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study L Beaugerie, N Brousse, AM Bouvier, JF Colombel, M Lémann, J Cosnes, ... The Lancet 374 (9701), 1617-1625, 2009 | 1286 | 2009 |
| Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial F Carrat, F Bani-Sadr, S Pol, E Rosenthal, F Lunel-Fabiani, A Benzekri, ... Jama 292 (23), 2839-2848, 2004 | 1031 | 2004 |
| Influenza vaccine: the challenge of antigenic drift F Carrat, A Flahault Vaccine 25 (39-40), 6852-6862, 2007 | 965 | 2007 |
| Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis D Saadoun, M Rosenzwajg, F Joly, A Six, F Carrat, V Thibault, D Sene, ... New England Journal of Medicine 365 (22), 2067-2077, 2011 | 868 | 2011 |
| Risk of serious and opportunistic infections associated with treatment of inflammatory bowel diseases J Kirchgesner, M Lemaitre, F Carrat, M Zureik, F Carbonnel, R Dray-Spira Gastroenterology 155 (2), 337-346. e10, 2018 | 602 | 2018 |
| Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study F Carrat, H Fontaine, C Dorival, M Simony, C Hezode, V De Ledinghen, ... The Lancet 393 (10179), 1453-1464, 2019 | 600 | 2019 |
| Association between use of thiopurines or tumor necrosis factor antagonists alone or in combination and risk of lymphoma in patients with inflammatory bowel disease M Lemaitre, J Kirchgesner, A Rudnichi, F Carrat, M Zureik, F Carbonnel, ... Jama 318 (17), 1679-1686, 2017 | 577 | 2017 |
| Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease L Peyrin–Biroulet, K Khosrotehrani, F Carrat, AM Bouvier, JB Chevaux, ... Gastroenterology 141 (5), 1621-1628. e5, 2011 | 573 | 2011 |
| Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC)–NCT01514890 C Hézode, H Fontaine, C Dorival, D Larrey, F Zoulim, V Canva, ... Journal of hepatology 59 (3), 434-441, 2013 | 563 | 2013 |
| The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis C Corpechot, F Carrat, A Bahr, Y Chrétien, RE Poupon, R Poupon Gastroenterology 128 (2), 297-303, 2005 | 495 | 2005 |
| A Bayesian MCMC approach to study transmission of influenza: application to household longitudinal data S Cauchemez, F Carrat, C Viboud, AJ Valleron, PY Boëlle Statistics in medicine 23 (22), 3469-3487, 2004 | 484 | 2004 |
| Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease L Beaugerie, M Svrcek, P Seksik, AM Bouvier, T Simon, M Allez, H Brixi, ... Gastroenterology 145 (1), 166-175. e8, 2013 | 441 | 2013 |
| Liver biopsy: the best, not the gold standard P Bedossa, F Carrat Journal of hepatology 50 (1), 1-3, 2009 | 441 | 2009 |
| Risk factors of influenza transmission in households C Viboud, PY Boëlle, S Cauchemez, A Lavenu, AJ Valleron, A Flahault, ... British Journal of General Practice 54 (506), 684-689, 2004 | 411 | 2004 |
| Noninvasive elastography‐based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis C Corpechot, F Carrat, A Poujol‐Robert, F Gaouar, D Wendum, ... Hepatology 56 (1), 198-208, 2012 | 410 | 2012 |
| The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis C Corpechot, F Carrat, AM Bonnand, RE Poupon, R Poupon Hepatology 32 (6), 1196-1199, 2000 | 409 | 2000 |
| Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis C Hézode, H Fontaine, C Dorival, F Zoulim, D Larrey, V Canva, ... Gastroenterology 147 (1), 132-142. e4, 2014 | 336 | 2014 |
| Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing … C Corpechot, F Gaouar, A El Naggar, A Kemgang, D Wendum, R Poupon, ... Gastroenterology 146 (4), 970-979. e6, 2014 | 335 | 2014 |
| Effect of influenza vaccination of nursing home staff on mortality of residents: a cluster‐randomized trial M Lemaitre, T Meret, M Rothan‐Tondeur, J Belmin, JL Lejonc, L Luquel, ... Journal of the American Geriatrics Society 57 (9), 1580-1586, 2009 | 324 | 2009 |
francis berenbaumAdresă de e-mail confirmată pe sat.aphp.fr
